Onderzoeksoutput per jaar
Onderzoeksoutput per jaar
- 1 - 50 van 203 resultaten
Zoekresultaten
-
2025
Establishment and characterization of ovarian clear cell carcinoma patient-derived xenografts
Caumanns, J. J., Li, S., Meersma, G. J., Duiker, E. W., van der Zee, A. G. J., Wisman, G. B. A. & de Jong, S., 5-feb.-2025, In: Scientific Reports. 15, 1, 15 blz., 4434.Onderzoeksoutput: Article › Academic › peer review
Open AccessBestand1 Citaat (Scopus)21 Downloads (Pure) -
Transcriptional pattern enriched for synaptic signaling is associated with shorter survival of patients with high-grade serous ovarian cancer
Bhattacharya, A., Stutvoet, T. S., Perla, M., Loipfinger, S., Jalving, M., Reyners, A. K. L., Vermeer, P. D., Drapkin, R., de Bruyn, M., de Vries, E. G. E., de Jong, S. & Fehrmann, R. S. N., 13-mei-2025, In: eLife. 13, 27 blz., RP101369.Onderzoeksoutput › Academic › peer review
Open AccessBestand -
2024
Everolimus decreases [U-13C]glucose utilization by pyruvate carboxylase in breast cancer cells in vitro and in vivo.
Ariaans, G., Tiersma, J. F., Evers, B., Gerding, A., Waaijer, S. J. H., Koster, R. A., Touw, D. J., Bakker, B. M., Reijngoud, D.-J., de Jong, S. & Jalving, M., apr.-2024, In: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 173, 10 blz., 116362.Onderzoeksoutput: Article › Academic › peer review
Open AccessBestand1 Citaat (Scopus)134 Downloads (Pure) -
Genome-wide DNA methylation in relation to ARID1A deficiency in ovarian clear cell carcinoma
Li, S., Meersma, G. J., Kupryjanczyk, J., de Jong, S. & Wisman, G. B. A., 2024, In: Journal of translational medicine. 22, 17 blz., 556.Onderzoeksoutput: Article › Academic › peer review
Open AccessBestand2 Citaten (Scopus)66 Downloads (Pure) -
Independent transcriptional patterns reveal biological processes associated with disease-free survival in early colorectal cancer
Knapen, D. G., Hone Lopez, S., de Groot, D. J. A., de Haan, J.-J., de Vries, E. G. E., Dienstmann, R., de Jong, S., Bhattacharya, A. & Fehrmann, R. S. N., 3-mei-2024, In: Communications medicine. 4, 10 blz., 79.Onderzoeksoutput: Article › Academic › peer review
Open AccessBestand65 Downloads (Pure) -
Mechanisms underlying reversed TRAIL sensitivity in acquired bortezomib-resistant non-small cell lung cancer cells
De Wilt, L., Sobocki, B. K., Jansen, G., Tabeian, H., de Jong, S., Peters, G. J. & Kruyt, F., 8-apr.-2024, In: Cancer Drug Resistance. 7, 21 blz., 12.Onderzoeksoutput: Article › Academic › peer review
Open AccessBestand4 Citaten (Scopus)74 Downloads (Pure) -
RAD51 recruitment but not replication fork stability associates with PARP inhibitor response in ovarian cancer patient-derived xenograft models
Talens, F., Oliviera Nunes Teixeira, V., Kok, Y. P., Chen, M., Rosenberg, E. H., Debipersad, R., Duiker, E. W., van den Tempel, N., Janatova, M., Zemankova, P., Nederlof, P. M., Wisman, G. B. A., Kleibl, Z., de Jong, S. & van Vugt, M. A. T. M., dec.-2024, In: NAR cancer. 6, 4, 18 blz., zcae044.Onderzoeksoutput: Article › Academic › peer review
Open AccessBestand42 Downloads (Pure) -
Targeting tumour metabolism in melanoma to enhance response to immune checkpoint inhibition: A balancing act
Tiersma, J. F., Evers, B., Bakker, B. M., Reijngoud, D. J., de Bruyn, M., de Jong, S. & Jalving, M., sep.-2024, In: CANCER TREATMENT REVIEWS. 129, 11 blz., 102802.Onderzoeksoutput: Review article › peer review
Open AccessBestand3 Citaten (Scopus)145 Downloads (Pure) -
2023
Correction: Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancer
de Heer, E. C., Zois, C. E., Bridges, E., van der Vegt, B., Sheldon, H., Veldman, W. A., Zwager, M. C., van der Sluis, T., Haider, S., Morita, T., Baba, O., Schröder, C. P., de Jong, S., Harris, A. L. & Jalving, M., 28-aug.-2023, In: Journal of experimental & clinical cancer research. 42, 1 blz., 220.Onderzoeksoutput: Erratum
Open AccessBestand52 Downloads (Pure) -
Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancer
de Heer, E. C., Zois, C. E., Bridges, E., van der Vegt, B., Sheldon, H., Veldman, W. A., Zwager, M. C., van der Sluis, T., Haider, S., Morita, T., Baba, O., Schröder, C. P., de Jong, S., Harris, A. L. & Jalving, M., 6-jun.-2023, In: Journal of experimental & clinical cancer research. 42, 14 blz., 143.Onderzoeksoutput: Article › Academic › peer review
Open AccessBestand12 Citaten (Scopus)122 Downloads (Pure) -
2022
NOTCH signaling limits the response of Low Grade Serous Ovarian Cancers to MEK inhibition
Llaurado Fernandez, M., Hijmans, E. M., Gennissen, A., Wong, N. K. Y., Li, S., Wisman, G. B. A., Hamilton, A., Hoenisch, J., Dawson, A., Lee, C.-H., Bittner, M., Kim, H., DiMattia, G. E., Lok, C. A. R., Lieftink, C., Beijersbergen, R. L., de Jong, S., Carey, M. S., Bernards, R. & Berns, K., 1-dec.-2022, In: Molecular cancer therapeutics. 21, 12, blz. 1862–1874 13 blz.Onderzoeksoutput: Article › Academic › peer review
Open AccessBestand6 Citaten (Scopus)125 Downloads (Pure) -
Pyruvate Dehydrogenase Kinase Inhibition by Dichloroacetate in Melanoma Cells Unveils Metabolic Vulnerabilities
Tiersma, J. F., Evers, B., Bakker, B. M., Jalving, M. & de Jong, S., 29-mrt.-2022, In: International Journal of Molecular Sciences. 23, 7, 17 blz., 3745.Onderzoeksoutput: Article › Academic › peer review
Open AccessBestand9 Citaten (Scopus)161 Downloads (Pure) -
2021
Author Correction: Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts (Nature Genetics, (2021), 53, 1, (86-99), 10.1038/s41588-020-00750-6)
PDXNET Consortium, EurOPDX Consortium, Woo, X. Y., Giordano, J., Srivastava, A., Zhao, Z. M., Lloyd, M. W., de Bruijn, R., Suh, Y. S., Patidar, R., Chen, L., Scherer, S., Bailey, M. H., Yang, C. H., Cortes-Sanchez, E., Xi, Y., Wang, J., Wickramasinghe, J., Kossenkov, A. V. & Rebecca, V. W. & 26 anderen, , mei-2021, In: Nature genetics. 53, 5, blz. 761 1 blz.Onderzoeksoutput: Erratum
Open AccessBestand4 Citaten (Scopus)78 Downloads (Pure) -
Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts
PDXNET Consortium, EurOPDX Consortium, Woo, X. Y., Giordano, J., Srivastava, A., Zhao, Z. M., Lloyd, M. W., de Bruijn, R., Suh, Y. S., Patidar, R., Chen, L., Scherer, S., Bailey, M. H., Yang, C. H., Cortes-Sanchez, E., Xi, Y., Wang, J., Wickramasinghe, J., Kossenkov, A. V. & Rebecca, V. W. & 6 anderen, , jan.-2021, In: Nature genetics. 53, blz. 86-99 14 blz.Onderzoeksoutput: Article › Academic › peer review
Open AccessBestand139 Citaten (Scopus)104 Downloads (Pure) -
Robust metabolic transcriptional components in 34,494 patient-derived cancer-related samples and cell lines
Leeuwenburgh, V. C., Urzua-Traslavina, C. G., Bhattacharya, A., Walvoort, M. T. C., Jalving, M., de Jong, S. & Fehrmann, R. S. N., 26-sep.-2021, In: Cancer & Metabolism. 9, 1, 15 blz., 35.Onderzoeksoutput: Article › Academic › peer review
Open AccessBestand83 Downloads (Pure) -
2020
Dual mTORC1/2 inhibition sensitizes testicular cancer models to cisplatin treatment
Rosas-Plaza, X., de Vries, G., Meersma, G. J., Suurmeijer, A. J. H., Gietema, J. A., van Vugt, M. A. T. M. & de Jong, S., feb.-2020, In: Molecular cancer therapeutics. 19, 2, blz. 590-601 13 blz.Onderzoeksoutput: Article › Academic › peer review
Open AccessBestand13 Citaten (Scopus)118 Downloads (Pure) -
Establishment and characterisation of testicular cancer patient-derived xenograft models for preclinical evaluation of novel therapeutic strategies
de Vries, G., Rosas-Plaza, X., Meersma, G. J., Leeuwenburgh, V. C., Kok, K., Suurmeijer, A. J. H., van Vugt, M. A. T. M., Gietema, J. A. & de Jong, S., 3-nov.-2020, In: Scientific Reports. 10, 1, blz. 1-15 15 blz., 18938.Onderzoeksoutput › Academic › peer review
Open AccessBestand6 Citaten (Scopus)131 Downloads (Pure) -
Kinome capture sequencing of high-grade serous ovarian carcinoma reveals novel mutations in theJAK3gene
Mittempergher, L., Piskorz, A. M., Bosma, A. J., Michaut, M., Wisman, G. B. A., Kluin, R. J. C., Nieuwland, M., Brugman, W., van der Ven, K. J. W., Marass, F., Morris, J., Rosenfeld, N., Jimenez-Linan, M., de Jong, S., van der Zee, A. G. J., Brenton, J. D. & Bernards, R., 8-jul.-2020, In: PLoS ONE. 15, 7, 22 blz., 0235766.Onderzoeksoutput: Article › Academic › peer review
Open AccessBestand3 Citaten (Scopus)160 Downloads (Pure) -
MDM2 inhibitors sensitize testicular cancer models to mTORC1/2 inhibitors and cisplatin
de Jong, S., de Vries, G., Meersma, G. J., Suurmeijer, A. J. H., van Vugt, M. A. T. M. & Gietema, J. A., aug.-2020. 2 blz.Onderzoeksoutput: Abstract › Academic
-
Molecular Imaging of PD-L1 Expression and Dynamics with the Adnectin-Based PET Tracer F-18-BMS-986192
Stutvoet, T. S., van der Veen, E. L., Kol, A., Antunes, I. F., de Vries, E. F. J., Hospers, G. A. P., de Vries, E. G. E., de Jong, S. & Lub-de Hooge, M. N., 1-dec.-2020, In: Journal of Nuclear Medicine. 61, 12, blz. 1839-1844 7 blz.Onderzoeksoutput: Article › Academic › peer review
Open AccessBestand44 Citaten (Scopus)123 Downloads (Pure) -
Targeting metabolism to improve response to immune-checkpoint inhibition in melanoma.
Tiersma, J. F., Evers, B., Bakker, B. M., de Jong, S. & Jalving, M., dec.-2020, In: Cancer Research. 80, 23, 1 blz.Onderzoeksoutput: Meeting Abstract › Academic
-
Testicular cancer: Determinants of cisplatin sensitivity and novel therapeutic opportunities: Determinants of cisplatin sensitivity and novel therapeutic opportunities
de Vries, G., Rosas-Plaza, X., van Vugt, M. A. T. M., Gietema, J. A. & de Jong, S., 1-aug.-2020, In: CANCER TREATMENT REVIEWS. 88, 12 blz., 102054.Onderzoeksoutput: Review article › peer review
Open AccessBestand108 Citaten (Scopus)324 Downloads (Pure) -
2019
Heightened JNK Activation and Reduced XIAP Levels Promote TRAIL and Sunitinib-Mediated Apoptosis in Colon Cancer Models
Mahalingam, D., Carew, J. S., Espitia, C. M., Cool, R. H., Giles, F. J., de Jong, S. & Nawrocki, S. T., 26-jun.-2019, In: Cancers. 11, 7, 18 blz., 895.Onderzoeksoutput: Article › Academic › peer review
Open AccessBestand13 Citaten (Scopus)173 Downloads (Pure) -
Low-dose triple drug combination targeting the PI3K/AKT/mTOR pathway and the MAPK pathway is an effective approach in ovarian clear cell carcinoma
Caumanns, J. J., van Wijngaarden, A., Kol, A., Meersma, G. J., Jalving, M., Bernards, R., van der Zee, A. G. J., Wisman, G. B. A. & de Jong, S., 2019, In: Cancer letters. 461, blz. 102-111 10 blz.Onderzoeksoutput › Academic › peer review
Open AccessBestand43 Citaten (Scopus)356 Downloads (Pure) -
MAPK pathway activity plays a key role in PD-L1 expression of lung adenocarcinoma cells
Stutvoet, T. S., Kol, A., de Vries, E. G. E., de Bruyn, M., Fehrmann, R. S. N., van Scheltinga, A. G. T. T. & de Jong, S., sep.-2019, In: The Journal of Pathology. 249, 1, blz. 52-64 13 blz.Onderzoeksoutput: Article › Academic › peer review
Open AccessBestand133 Citaten (Scopus)472 Downloads (Pure) -
miR-371a-3p, miR-373-3p and miR-367-3p as Serum Biomarkers in Metastatic Testicular Germ Cell Cancers Before, During and After Chemotherapy
Rosas Plaza, X., van Agthoven, T., Meijer, C., van Vugt, M. A. T. M., de Jong, S., Gietema, J. A. & Looijenga, L. H. J., okt.-2019, In: Cells. 8, 10, 14 blz., 1221.Onderzoeksoutput: Article › Academic › peer review
Open AccessBestand52 Citaten (Scopus)200 Downloads (Pure) -
Multiple Interactions Between Cancer Cells and the Tumor Microenvironment Modulate TRAIL Signaling: Implications for TRAIL Receptor Targeted Therapy
de Looff, M., de Jong, S. & Kruyt, F. A. E., 3-jul.-2019, In: Frontiers in Immunology. 10, 15 blz., 1530.Onderzoeksoutput: Review article › peer review
Open AccessBestand64 Citaten (Scopus)272 Downloads (Pure) -
2018
ARID1A mutant ovarian clear cell carcinoma: A clear target for synthetic lethal strategies
Caumanns, J. J., Wisman, G. B. A., Berns, K., van der Zee, A. G. J. & de Jong, S., dec.-2018, In: Biochimica et biophysica acta-Reviews on cancer. 1870, 2, blz. 176-184 9 blz.Onderzoeksoutput: Review article › peer review
Open AccessBestand71 Citaten (Scopus)630 Downloads (Pure) -
ARID1A mutation sensitizes most ovarian clear cell carcinomas to BET inhibitors
Berns, K., Caumanns, J. J., Hijmans, E. M., Gennissen, A. M. C., Severson, T. M., Evers, B., Wisman, G. B. A., Jan Meersma, G., Lieftink, C., Beijersbergen, R. L., Itamochi, H., van der Zee, A. G. J., de Jong, S. & Bernards, R., 16-aug.-2018, In: Oncogene. 37, 33, blz. 4611-4625 15 blz.Onderzoeksoutput: Article › Academic › peer review
Open AccessBestand86 Citaten (Scopus)378 Downloads (Pure) -
Avenues to molecular imaging of dying cells: Focus on cancer
Rybczynska, A., Boersma, H., de Jong, S., Gietema, J. A., Noordzij, W., Dierckx, R., Elsinga, P. H. & van Waarde, A., nov.-2018, In: Medicinal research reviews. 38, 6, blz. 1713-1768 56 blz.Onderzoeksoutput › peer review
Open AccessBestand33 Citaten (Scopus)319 Downloads (Pure) -
Heart Failure Stimulates Tumor Growth by Circulating Factors
Meijers, W. C., Maglione, M., Bakker, S. J. L., Oberhuber, R., Kieneker, L. M., de Jong, S., Haubner, B. J., Nagengast, W. B., Lyon, A. R., van der Vegt, B., van Veldhuisen, D. J., Westenbrink, B. D., van der Meer, P., Silljé, H. H. W. & de Boer, R. A., 14-aug.-2018, In: Circulation. 138, 7, blz. 678-691 14 blz.Onderzoeksoutput: Article › Academic › peer review
Open Access290 Citaten (Scopus) -
Integrative Kinome Profiling Identifies mTORC1/2 Inhibition as Treatment Strategy in Ovarian Clear Cell Carcinoma
Caumanns, J. J., Berns, K., Wisman, G. B. A., Fehrmann, R. S. N., Tomar, T., Klip, H., Meersma, G. J., Hijmans, E. M., Gennissen, A., Duiker, E. W., Weening, D., Itamochi, H., Kluin, R. J., Reyners, A. K. L., Birrer, M. J., Salvesen, H. B., Vergote, I., Van Nieuwenhuysen, E., Brenton, J. D. & Braicu, E. I. & 6 anderen, , 15-aug.-2018, In: Clinical Cancer Research. 24, 16, blz. 3928-3940 13 blz.Onderzoeksoutput: Article › Academic › peer review
Open AccessBestand36 Citaten (Scopus)79 Downloads (Pure) -
MAPK pathway activity plays a key role in programmed death ligand-1 expression of EGFR wild-type non-small cell lung adenocarcinoma cells
Stutvoet, T., Kol, A., de Vries, E., de Bruyn, M., Fehrmann, R., van Scheltinga, A. T. & de Jong, S., nov.-2018, blz. E78-E79. 2 blz.Onderzoeksoutput: Poster › Academic
-
The metabolic landscape browser: a novel tool for understanding pan-cancer metabolic processes through variance in gene expression data
Leeuwenburgh, V., Bhattacharya, A., Urzua, C., Walvoort, M., Jalving, H., de Jong, S. & Fehrmann, R., nov.-2018, In: European Journal of Cancer. 103, Suppl.1, blz. E106-E106 1 blz., 318 (PB-079).Onderzoeksoutput › Academic
Open AccessBestand6837 Downloads (Pure) -
2017
(89)Zr-mAb3481 PET for HER3 tumor status assessment during lapatinib treatment
Pool, M., Kol, A., de Jong, S., de Vries, E. G. E., Lub-de Hooge, M. N. & Terwisscha van Scheltinga, A. G. T., 2017, In: mAbs. 9, blz. 1370-1378 9 blz.Onderzoeksoutput: Article › Academic › peer review
Open AccessBestand19 Citaten (Scopus)324 Downloads (Pure) -
ADCC responses and blocking of EGFR-mediated signaling and cell growth by combining the anti-EGFR antibodies imgatuzumab and cetuximab in NSCLC cells
Kol, A., Terwisscha van Scheltinga, A., Pool, M., Gerdes, C., de Vries, E. & de Jong, S., 11-jul.-2017, In: Oncotarget. 8, 28, blz. 45432-45446 15 blz.Onderzoeksoutput: Article › Academic › peer review
Open AccessBestand24 Citaten (Scopus)358 Downloads (Pure) -
Anti-tumor effects of everolimus and metformin are complementary and glucose-dependent in breast cancer cells
Ariaans, G., Jalving, M., de Vries, E. G. E. & de Jong, S., 29-mrt.-2017, In: BMC Cancer. 17, 232, blz. 232 13 blz.Onderzoeksoutput › Academic › peer review
Open AccessBestand45 Citaten (Scopus)492 Downloads (Pure) -
Functional Genomic mRNA Profiling of Colorectal Adenomas: Identification and in vivo Validation of CD44 and Splice Variant CD44v6 as Molecular Imaging Targets
Hartmans, E., Orian-Rousseau, V., Matzke-Ogi, A., Karrenbeld, A., de Groot, D. J. A., de Jong, S., van Dam, G. M., Fehrmann, R. S. N. & Nagengast, W. B., 6-jan.-2017, In: Theranostics. 7, 2, blz. 482-492 11 blz.Onderzoeksoutput › Academic › peer review
Open AccessBestand12 Citaten (Scopus)303 Downloads (Pure) -
IGF system targeted therapy: Therapeutic opportunities for ovarian cancer
Liefers-Visser, J. A. L., Meijering, R. A. M., Reyners, A. K. L., van der Zee, A. G. J. & de Jong, S., nov.-2017, In: CANCER TREATMENT REVIEWS. 60, blz. 90-99 10 blz.Onderzoeksoutput › peer review
Open AccessBestand68 Citaten (Scopus)398 Downloads (Pure) -
Integrative kinome exome sequencing and copy number profiling of ovarian clear cell carcinoma
Caumanns, J. J., Wisman, G. B. A., Berns, K., Tomar, T., Fehrmann, R. S. N., Bernards, R., Van der Zee, A. G. J. & De Jong, S., jul.-2017, In: Cancer Research. 77, 13 Supplement, 2 blz., 1219.Onderzoeksoutput: Meeting Abstract › Academic
-
Interrogating open issues in cancer precision medicine with patient-derived xenografts
Byrne, A. T., Alferez, D. G., Amant, F., Annibali, D., Arribas, J., Biankin, A. V., Bruna, A., Budinska, E., Caldas, C., Chang, D. K., Clarke, R. B., Clevers, H., Coukos, G., Dangles-Marie, V., Eckhardt, S. G., Gonzalez-Suarez, E., Hermans, E., Hidalgo, M., Jarzabek, M. A. & de Jong, S. & 23 anderen, , apr.-2017, In: Nature reviews cancer. 17, 4, blz. 254-268 15 blz.Onderzoeksoutput › peer review
Open Access577 Citaten (Scopus) -
Methylome analysis of extreme chemoresponsive patients identifies novel markers of platinum sensitivity in high-grade serous ovarian cancer
Tomar, T., Alkema, N. G., Schreuder, L., Meersma, G. J., Meyer, T., Van Criekinge, W., Klip, H. G., Fiegl, H., Van Nieuwenhuysen, E., Vergote, I., Widschwendter, M., Schuuring, E., van der Zee, A. G. J., de Jong, S. & Wisman, G. B. A., 23-jun.-2017, In: BMC Medicine. 15, 1, 16 blz., 116.Onderzoeksoutput: Article › Academic › peer review
Open AccessBestand41 Citaten (Scopus)366 Downloads (Pure) -
2016
Extracellular domain shedding influences specific tumor uptake and organ distribution of the EGFR PET tracer 89Zr-imgatuzumab
Pool, M., Kol, A., Lub-de Hooge, M. N., Gerdes, C. A., de Jong, S., Vries, de, E. G. E. & Terwisscha van Scheltinga, A. G. T., 18-okt.-2016, In: Oncotarget. 7, 42, blz. 68111-68121 11 blz.Onderzoeksoutput: Article › Academic › peer review
Open AccessBestand15 Citaten (Scopus)297 Downloads (Pure) -
Genome-wide methylation profiling of ovarian cancer patient-derived xenografts treated with the demethylating agent decitabine identifies novel epigenetically regulated genes and pathways
Tomar, T., de Jong, S., Alkema, N. G., Hoekman, R. L., Meersma, G. J., Klip, H. G., van der Zee, A. G. & Wisman, G. B. A., 20-okt.-2016, In: Genome medicine. 8, 107, 15 blz.Onderzoeksoutput: Article › Academic › peer review
Open AccessBestand34 Citaten (Scopus)441 Downloads (Pure) -
Studying platinum sensitivity and resistance in high-grade serous ovarian cancer: Different models for different questions
Alkema, N. G., Wisman, G. B. A., van der Zee, A. G. J., van Vugt, M. A. T. M. & de Jong, S., jan.-2016, In: Drug Resistance Updates. 24, blz. 55-69 15 blz.Onderzoeksoutput › peer review
63 Citaten (Scopus) -
Treatment Regimen, Surgical Outcome, and T-cell Differentiation Influence Prognostic Benefit of Tumor-Infiltrating Lymphocytes in High-Grade Serous Ovarian Cancer
Wouters, M. C. A., Komdeur, F. L., Workel, H. H., Klip, H. G., Plat, A., Kooi, N. M., Wisman, G. B. A., Mourits, M. J. E., Arts, H. J. G., Oonk, M. H. M., Yigit, R., de Jong, S., Melief, C. J. M., Hollema, H., Duiker, E. W., Daemen, T., de Bruyn, M. & Nijman, H. W., 1-feb.-2016, In: Clinical Cancer Research. 22, 3, blz. 714-724 11 blz.Onderzoeksoutput: Article › Academic › peer review
61 Citaten (Scopus) -
2015
Biobanking of patient and patient-derived xenograft ovarian tumour tissue: efficient preservation with low and high fetal calf serum based methods
Alkema, N. G., Tomar, T., Duiker, E. W., Meersma, G. J., Klip, H., van der Zee, A. G. J., Wisman, G. B. A. & de Jong, S., 6-okt.-2015, In: Scientific Reports. 5, 12 blz., 14495.Onderzoeksoutput › Academic › peer review
Open AccessBestand44 Citaten (Scopus)470 Downloads (Pure) -
Cancer-drug induced insulin resistance: Innocent bystander or unusual suspect
Ariaans, G., de Jong, S., Gietema, J. A., Lefrandt, J. D., de Vries, E. G. E. & Jalving, M., apr.-2015, In: CANCER TREATMENT REVIEWS. 41, 4, blz. 376-384 9 blz.Onderzoeksoutput › peer review
48 Citaten (Scopus) -
Molecular Imaging As a Tool for Drug Development and Trial Design
de Vries, E. G. E., de Jong, S. & Gietema, J. A., 20-aug.-2015, In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 33, 24, blz. 2585-2587 3 blz.Onderzoeksoutput: Editorial › Academic › peer review
26 Citaten (Scopus) -
2014
Checkpoint kinase 2 (Chk2) supports sensitivity to platinum-based treatment in high grade serous ovarian cancer
Alkema, N. G., Tomar, T., van der Zee, A. G. J., Everts, M., Meersma, G. J., Hollema, H., de Jong, S., van Vugt, M. A. T. M. & Wisman, G. B. A., jun.-2014, In: Gynecologic Oncology. 133, 3, blz. 591-598 8 blz.Onderzoeksoutput › Academic › peer review
26 Citaten (Scopus)